George Grove
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
George Grove has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Eric D. Vidoni
Department of Neurology, University of Kansas Medical Center, Kansas City, USA
4 shared publications - Lu Wan
AdventHealth Research Institute, Neuroscience Institute, Orlando, USA
4 shared publications Arthur F. Kramer
Department of Psychology, University of Illinois Urbana-Champaign, Urbana, USA
3 shared publications- Chaeryon Kang
Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, USA
3 shared publications - Charles H. Hillman
Department of Psychology, Northeastern University, Boston, USA
3 shared publications - Edward McAuley
Department of Health and Kinesiology, University of Illinois Urbana-Champaign, Urbana, USA
3 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by Springer Nature in GeroScience
- p. 1-16
Loneliness relates to smaller hippocampal subfield volumes in individuals with elevated plasma pTau217: results from IGNITE
- 23 October 2026
- Published by Springer Nature in GeroScience
- p. 1-16
Open AccessLoneliness relates to smaller hippocampal subfield volumes in individuals with elevated plasma pTau217: results from IGNITE
- Open Access
- 25 June 2026
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 55, 101291
Inflammatory, metabolic, and vascular pathways linking cardiorespiratory fitness to cognition: Results from the IGNITE study
- 25 June 2026
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 55, 101291
Open AccessInflammatory, metabolic, and vascular pathways linking cardiorespiratory fitness to cognition: Results from the IGNITE study
- Open Access
- 12 May 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (9) , e214833
Cognitive and Brain Reserve as Modifiers of Early Alzheimer Disease–Related Cognitive Vulnerability
Maintaining cognitive function despite the presence of Alzheimer disease (AD) pathology is the foundation of cognitive reserve. Although the theory of cognitive reserve is strongly supported by empirical research, the field lacks standardized, validated methods for quantifying cognitive and brain reserve. We tested whether associations between AD pathology and cognitive function were modified by proxy measures of cognitive reserve (years of education, socioeconomic status; SES) and brain reserve (brain-predicted age difference, and a volumetric AD signature). We hypothesized that greater structural brain integrity, higher education, and higher SES would attenuate the association between greater AD pathology and poorer cognitive performance. This cross-sectional study analyzed baseline data from a multisite randomized clinical trial, which was conducted at 3 US universities and enrolled cognitively unimpaired, physically inactive, community-dwelling adults. AD pathology was measured via plasma assays for phosphorylated tau (p-tau)-217 in the whole cohort, and PET for β-amyloid (Aβ) in a subset of participants as a secondary analysis. The primary outcome of cognitive function was evaluated by a comprehensive cognitive assessment. SES was measured via the MacArthur Socioeconomic Status Index, and magnetic resonance imaging was used to calculate brain-predicted age difference (brain-PAD) and a volumetric AD signature. Data were analyzed using linear regression models with interaction terms for moderation analyses. A total of 621 participants (aged 69.9 ± 3.8, 71% female) had available data for the main analyses and 355 had PET Centiloid data available. Brain-PAD moderated the association between AD pathology (measured by p-tau217) and multiple cognitive domains, including episodic memory (β = -0.09 [-0.16 to -0.02]), processing speed (β = -0.08 [-0.15 to -0.01]), working memory (β = -0.10 [-0.18 to -0.03]), and executive function/attentional control (β = -0.08 [-0.15 to -0.01]). Specifically, the negative association of greater AD pathology with poorer cognition was weakest in individuals with younger appearing brains. A latent SES score also moderated the relationship between p-tau217 and episodic memory (β = 0.08 [0.01-0.16]), but this did not survive correction for multiple comparisons. Neither years of education nor the volumetric AD signature moderated pathology-cognition associations. These results support the hypothesis that higher cognitive and brain reserve may help buffer the cognitive consequences of AD pathology. Strategies to increase both cognitive and brain reserve could help to boost resilience against emerging AD pathology; however, longitudinal studies are needed to confirm these conclusions.
- 12 May 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (9) , e214833
Open AccessCognitive and Brain Reserve as Modifiers of Early Alzheimer Disease–Related Cognitive Vulnerability
Maintaining cognitive function despite the presence of Alzheimer disease (AD) pathology is the foundation of cognitive reserve. Although the theory of cognitive reserve is strongly supported by empirical research, the field lacks standardized, validated methods for quantifying cognitive and brain reserve. We tested whether associations between AD pathology and cognitive function were modified by proxy measures of cognitive reserve (years of education, socioeconomic status; SES) and brain reserve (brain-predicted age difference, and a volumetric AD signature). We hypothesized that greater structural brain integrity, higher education, and higher SES would attenuate the association between greater AD pathology and poorer cognitive performance. This cross-sectional study analyzed baseline data from a multisite randomized clinical trial, which was conducted at 3 US universities and enrolled cognitively unimpaired, physically inactive, community-dwelling adults. AD pathology was measured via plasma assays for phosphorylated tau (p-tau)-217 in the whole cohort, and PET for β-amyloid (Aβ) in a subset of participants as a secondary analysis. The primary outcome of cognitive function was evaluated by a comprehensive cognitive assessment. SES was measured via the MacArthur Socioeconomic Status Index, and magnetic resonance imaging was used to calculate brain-predicted age difference (brain-PAD) and a volumetric AD signature. Data were analyzed using linear regression models with interaction terms for moderation analyses. A total of 621 participants (aged 69.9 ± 3.8, 71% female) had available data for the main analyses and 355 had PET Centiloid data available. Brain-PAD moderated the association between AD pathology (measured by p-tau217) and multiple cognitive domains, including episodic memory (β = -0.09 [-0.16 to -0.02]), processing speed (β = -0.08 [-0.15 to -0.01]), working memory (β = -0.10 [-0.18 to -0.03]), and executive function/attentional control (β = -0.08 [-0.15 to -0.01]). Specifically, the negative association of greater AD pathology with poorer cognition was weakest in individuals with younger appearing brains. A latent SES score also moderated the relationship between p-tau217 and episodic memory (β = 0.08 [0.01-0.16]), but this did not survive correction for multiple comparisons. Neither years of education nor the volumetric AD signature moderated pathology-cognition associations. These results support the hypothesis that higher cognitive and brain reserve may help buffer the cognitive consequences of AD pathology. Strategies to increase both cognitive and brain reserve could help to boost resilience against emerging AD pathology; however, longitudinal studies are needed to confirm these conclusions.
- Open Access
Fitness and Exercise Effects on Brain Age: A Randomized Clinical Trial
Objectives: Examine the effect of aerobic exercise on structural brain age and explore potential mediators. Methods: In a single-blind, 12-month randomized clinical trial, 130 healthy participants aged 26-58 years were randomized into a moderator-to-vigorous intensity aerobic exercise group or a usual-care control group. The exercise group attended 2 supervised 60-minute sessions per week in a laboratory setting plus home-based exercise to achieve 150 minutes of exercise per week. Brain-predicted age difference (brain-PAD) and cardiorespiratory fitness (CRF) were assessed at baseline and 12 months. Intention-to-treat (ITT) and completers analyses were performed. Results: The 130 participants (67.7% female) had a mean (SD) age of 41.28 (9.93) years. At baseline, higher CRF (VO 2peak ) was associated with smaller brain-PAD (β=-0.309, p=0.012). After the intervention, the exercise group showed a decrease in brain-PAD (estimated mean difference (EMD) =-0.60; 95% CI: -1.15 to -0.04; p=0.034) compared to the control group (EMD=0.35; 95% CI: -0.21 to 0.92; p=0.22); time×group interaction (between-group difference (BGD)= -0.95; 95% CI: -1.72 to -0.17; p=0.019). VO 2peak improved in the exercise group (EMD=1.60; 95% CI: 0.29 to 2.90; p=0.017) compared to the control group (EMD=-0.78; 95% CI: -2.17 to 0.60; p=0.26); time×group interaction (BGD=2.38; 95% CI: 0.52 to 4.25; p=0.015). Body composition, blood pressure, and brain-derived neurotrophic factor levels were unaffected. None of the proposed pathways statistically mediated the effect of exercise on brain-PAD. The results from completers were similar. Conclusion: Engaging in 12 months of moderate-to-vigorous exercise reduced brain-PAD in early-to-midlife adults. The pathways by which these effects occur remain unknown. Summary Box: What is already known on this topic: Midlife risk factors influence brain aging, with physical activity conferring protective benefits, yet evidence for the effect of exercise on midlife brain age and underlying mechanisms remains limited. What this study adds: Participation in a 12-month aerobic exercise intervention significantly reduced a neuroimaging marker of brain age. Higher cardiorespiratory fitness was also associated with younger brain age. How this study might affect research, practice or policy: Findings of this study complement the scarce literature examining the effects of exercise on early-to-midlife brain health and confirm the neuroprotective effects of aerobic exercise against accelerated brain aging in early-to-midlife adults.
Open AccessFitness and Exercise Effects on Brain Age: A Randomized Clinical Trial
Objectives: Examine the effect of aerobic exercise on structural brain age and explore potential mediators. Methods: In a single-blind, 12-month randomized clinical trial, 130 healthy participants aged 26-58 years were randomized into a moderator-to-vigorous intensity aerobic exercise group or a usual-care control group. The exercise group attended 2 supervised 60-minute sessions per week in a laboratory setting plus home-based exercise to achieve 150 minutes of exercise per week. Brain-predicted age difference (brain-PAD) and cardiorespiratory fitness (CRF) were assessed at baseline and 12 months. Intention-to-treat (ITT) and completers analyses were performed. Results: The 130 participants (67.7% female) had a mean (SD) age of 41.28 (9.93) years. At baseline, higher CRF (VO 2peak ) was associated with smaller brain-PAD (β=-0.309, p=0.012). After the intervention, the exercise group showed a decrease in brain-PAD (estimated mean difference (EMD) =-0.60; 95% CI: -1.15 to -0.04; p=0.034) compared to the control group (EMD=0.35; 95% CI: -0.21 to 0.92; p=0.22); time×group interaction (between-group difference (BGD)= -0.95; 95% CI: -1.72 to -0.17; p=0.019). VO 2peak improved in the exercise group (EMD=1.60; 95% CI: 0.29 to 2.90; p=0.017) compared to the control group (EMD=-0.78; 95% CI: -2.17 to 0.60; p=0.26); time×group interaction (BGD=2.38; 95% CI: 0.52 to 4.25; p=0.015). Body composition, blood pressure, and brain-derived neurotrophic factor levels were unaffected. None of the proposed pathways statistically mediated the effect of exercise on brain-PAD. The results from completers were similar. Conclusion: Engaging in 12 months of moderate-to-vigorous exercise reduced brain-PAD in early-to-midlife adults. The pathways by which these effects occur remain unknown. Summary Box: What is already known on this topic: Midlife risk factors influence brain aging, with physical activity conferring protective benefits, yet evidence for the effect of exercise on midlife brain age and underlying mechanisms remains limited. What this study adds: Participation in a 12-month aerobic exercise intervention significantly reduced a neuroimaging marker of brain age. Higher cardiorespiratory fitness was also associated with younger brain age. How this study might affect research, practice or policy: Findings of this study complement the scarce literature examining the effects of exercise on early-to-midlife brain health and confirm the neuroprotective effects of aerobic exercise against accelerated brain aging in early-to-midlife adults.
- Open Access
- 1 December 2020
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 20, 100666
The IGNITE trial: Participant recruitment lessons prior to SARS-CoV-2
- 1 December 2020
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 20, 100666
Open AccessThe IGNITE trial: Participant recruitment lessons prior to SARS-CoV-2